Tiapride

Suppliers

Names

[ CAS No. ]:
51012-32-9

[ Name ]:
Tiapride

[Synonym ]:
N-[2-(Diethylamino)ethyl]-5-(methylsulfonyl)-o-anisamide hydrochloride
N-[2-(diethylamino)ethyl]-2-methoxy-5-methylsulfonylbenzamide
EINECS 256-907-9
N-(2-(Diethylamino)ethyl)-2-methoxy-5-(methylsulfonyl)benzamide
MFCD00242730

Chemical & Physical Properties

[ Density]:
1.15 g/cm3

[ Boiling Point ]:
498.1ºC at 760 mmHg

[ Melting Point ]:
120ºC

[ Molecular Formula ]:
C15H24N2O4S

[ Molecular Weight ]:
328.42700

[ Flash Point ]:
255.1ºC

[ Exact Mass ]:
328.14600

[ PSA ]:
87.58000

[ LogP ]:
2.82590

[ Storage condition ]:
2-8°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CV4203700
CHEMICAL NAME :
Benzamide, N-(2-(diethylamino)ethyl)-2-methoxy-5-(methylsulfonyl )-
CAS REGISTRY NUMBER :
51012-32-9
LAST UPDATED :
199612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C15-H24-N2-O4-S
MOLECULAR WEIGHT :
328.47

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
1197 mg/kg
SEX/DURATION :
female 38 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - uterus, cervix, vagina
REFERENCE :
THERAP Therapie. (Doin, Editeurs, 8, Place de l'Odeon, F-75006 Paris, France) V.1- 1946- Volume(issue)/page/year: 30,231,1975
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
850 mg/kg
SEX/DURATION :
female 27 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - menstrual cycle changes or disorders
REFERENCE :
THERAP Therapie. (Doin, Editeurs, 8, Place de l'Odeon, F-75006 Paris, France) V.1- 1946- Volume(issue)/page/year: 30,231,1975

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
2

[ RTECS ]:
CV4203800

[ HS Code ]:
2924299090

Customs

[ HS Code ]: 2924299090

[ Summary ]:
2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Articles

Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease.

Brain 138 , 3221-37, (2015)

Polyglutamine diseases are a class of dominantly inherited neurodegenerative disorders for which there is no effective treatment. Here we provide evidence that activation of serotonergic signalling is...

German insurer finds a third of people over 65 take five or more drugs a day.

BMJ 346 , f3905, (2013)

Pharmacological treatment of tic disorders and Tourette Syndrome.

Neuropharmacology 68 , 143-9, (2013)

The present review gives an overview of current pharmacological treatment options of tic disorders and Tourette Syndrome (TS). After a short summary on phenomenology, clinical course and comorbid cond...


More Articles

Related Compounds

  • tiapride n-oxide
  • tiapride chlorhydrate
  • 1-Cyclopropanecarbonyl-4-[(3-fluoro-4-methoxyphenyl)methyl]-1,4-diazepane
  • 6-(difluoromethyl)-2-methyl-N-[2-(trifluoromethoxy)phenyl]pyrimidine-4-carboxamide
  • N-({1-[(4-cyanophenyl)methyl]-4-fluoropiperidin-4-yl}methyl)oxolane-3-carboxamide
  • 1-Methanesulfonyl-4-(5-methylpyrimidin-2-yl)-1,4-diazepane
  • 4-(6-{4-[2-(Methylsulfanyl)pyrimidin-4-yl]piperazin-1-yl}pyridazin-3-yl)morpholine
  • 1-(2H3)methyl-1H-pyrazole-4-carbaldehyde
  • 2-[5-(methoxymethyl)-1-pentyl-1H-1,2,3-triazol-4-yl]acetonitrile
  • 4-(2-{4-[2-(Methylsulfanyl)pyrimidin-4-yl]piperazin-1-yl}pyrimidin-4-yl)morpholine
  • 4-(6-{4-[2-(Methylsulfanyl)pyrimidin-4-yl]piperazin-1-yl}pyrimidin-4-yl)morpholine
  • 4-(4-{4-[2-(Methylsulfanyl)pyrimidin-4-yl]piperazin-1-yl}pyrimidin-2-yl)morpholine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.